ENERGI-F701 for Female Hair Loss Treatment

Inclusion criteria

• Female, aged at least 20 years old
• With hair loss over 100 hairs/day
• Willing to maintain the same hair style, color, shampoo and hair products used, and approximate hair length starting from signing ICF and throughout the study
• The subject of childbearing potential must show a negative urine or serum pregnancy test at Screening Visit
• Have signed the written informed consent form

Exclusion criteria

Any subject meeting any of the exclusion criteria will be excluded from study participation.

• With alopecia areata or cicatricial alopecia
• With other scalp or hair disorders
• With prior hair transplant
• Use wigs or hair weaves
• Plan to use any other concomitant therapy to treat hair loss, regrowth or volume during the study
• Have taken any topical or systemic prescription of OTC medications for treating hair loss, hair regrowth and/or hair volume
• Have used medications known to cause hair thinning, such as Coumadin and anti-depressants/anti-psychotics
• Have received chemotherapy/cytotoxic agents as well as radiation/laser/surgical therapy of the scalp
• Have initiated or terminated the use of hormones for birth control or hormone replacement therapy within 6 months. Subject will also be excluded from the study if she plans to initiate or terminate the use of hormones for birth control or hormone replacement therapy during the study.
• With known or suspected hypersensitivity any ingredients of study product and active control
• Any hematologic abnormalities.
• Any serum chemistry abnormalities.
• Pregnant, lactating, or premenopausal with childbearing potential but not adopting at least one form of birth control.
• Enrollment in any investigational drug trial
• With any condition judged by the investigator that entering the trial may be detrimental to the subject